Bafna Pharmaceuticals Limited, headquartered in Chennai, India, specializes in the production and distribution of a wide range of pharmaceutical formulations within the Indian market. With a foundation dating back to 1981, the company offers various types of tablets, including delayed and sustained release, chewable, and orally disintegrating options. In addition to serving the domestic market, Bafna Pharmaceuticals Limited also exports its high-quality products to international destinations.
Bafna Pharmaceuticals Limited
- 79.35 -1.73(-2.13%) 82.50 1.50(1.85%)
Live Bafna Pharmaceuticals Limited Share Price Chart
Bafna Pharmaceuticals Limited Share Performance
| Today's Low | Today's High | |
|---|---|---|
| 78.50 82.50 | 82.94 84.48 |
| 52 Week Low | 52 Week High | |
|---|---|---|
| 73.25 (24-Jun-2024) 73.35 (24-Jun-2024) | 113.00 (07-May-2024) 112.20 (07-May-2024) |
- Open
- 80.00 84.48
- Previous Close
- 81.08 81.00
- Volume
- 0.05
- Total Traded value
- 0.04 (Lakhs)
- Upper circuit
- 85.13 105.64
- Lower circuit
- 77.02 95.58
Bafna Pharmaceuticals Limited Share Market Depth
| Buy Order Quantity | Sell Order Quantity | |
|---|---|---|
| 2,857 | 1,939 |
| Bid Price | Quantity |
|---|---|
| 79.35 | 105.00 |
| 79.00 | 2.00 |
| 78.89 | 2.00 |
| 78.64 | 100.00 |
| 78.63 | 50.00 |
| Total: | 2,857 |
| Ask Price | Quantity |
|---|---|
| 80.99 | 27.00 |
| 81.00 | 62.00 |
| 82.49 | 100.00 |
| 82.50 | 100.00 |
| 82.99 | 100.00 |
| Total: | 1,939 |
Bafna Pharmaceuticals Limited Share Fundamentals
| Market Cap: | 1.88 Cr |
| PE Ratio (TTM): | 485.29 |
| PB Ratio: | 2.36 |
| Industry P/E: | 255.13 |
| Debt to Equity: | - |
| ROE: | 0.49 |
| EPS (TTM): | 0.17 |
| Book Value: | 186.27 |
| Face Value: | 10.00 |
Bafna Pharmaceuticals Limited Stock Financials
| Sep, 2022 | Sep, 2023 | Jun, 2023 | Sep, 2022 | Mar, 2023 | |
|---|---|---|---|---|---|
| Revenue | 209.73 Cr | 99.65 Cr | 1,117.14 Cr | 19.63 Cr | 42.24 Cr |
| Profit | 0.55 Cr | 1.18 Cr | 23.70 Cr | 0.66 Cr | 5.37 Cr |
| Expense | 209.75 Cr | 98.41 Cr | 1,051.36 Cr | 18.79 Cr | 36.85 Cr |
| Comprehensive income | 0.53 Cr | 1.18 Cr | 50.18 Cr | 0.66 Cr | 5.54 Cr |
| EPS | 0.30 | 0.18 | 2.14 | 0.56 | 2.34 |
| Company name | Listing date | Industry | NSE symbol BSE symbol |
|---|---|---|---|
| Bafna Pharmaceuticals Limited | Feb, 2020 Jun, 2008 | Pharmaceuticals Pharmaceuticals | BAFNAPH BAFNAPH |
Bafna Pharmaceuticals Limited Stock Shareholding pattern
Sep, 2023 Jun, 2023 Mar, 2023 Dec, 2022 Sep, 2022
Bafna Pharmaceuticals Limited Share FAQ's
What is the range of today's stock performance for Bafna Pharmaceuticals Limited?
Today's stock performance witnessed a fluctuation from a minimum of 78.50 on the NSE (National Stock Exchange) to a maximum of 82.94. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 82.50 to a high of 84.48.
What are the 52-week low and high values for Bafna Pharmaceuticals Limited?
The stock's performance over the past 52 weeks reveals a low of 73.25 (occurred on 24-Jun-2024) and a high of 113.00 (achieved on 07-May-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 73.35 (on 24-Jun-2024), and the 52-week high is 112.20 (on 07-May-2024).
What was the opening and previous closing prices for Bafna Pharmaceuticals Limited?
The stock's performance over the past 52 weeks reveals a low of 73.25 (occurred on 24-Jun-2024) and a high of 113.00 (achieved on 07-May-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 73.35 (on 24-Jun-2024), and the 52-week high is 112.20 (on 07-May-2024).
What is the total volume and traded value for Bafna Pharmaceuticals Limited for the day?
The total volume is 0, and the total traded value is 0.04 ( Lakhs).
What are the upper and lower circuit limits for Bafna Pharmaceuticals Limited?
The upper circuit limit is 85.13, and the lower circuit limit is 77.02.
What is the market cap and PE ratio for Bafna Pharmaceuticals Limited?
The market cap is 1.88 Cr, and the PE ratio (TTM) is 471.50.
What is the PB ratio, industry P/E, and debt to equity ratio for Bafna Pharmaceuticals Limited?
The PB ratio is 0.43, industry P/E is 255.13 .
What are the financial metrics such as ROE, EPS, dividend yield, book value, and face value for Bafna Pharmaceuticals Limited?
ROE is 0.49, EPS is 0.17, book value is 186.27
What are the revenue and profit figures for the latest quarter and previous quarters for Bafna Pharmaceuticals Limited?
In Sep 2022, Revenue is 2097264000, and Profit is 5549000. In Sep 2023, Revenue is 996490000.00, and Profit is 11803000.00.
When was Bafna Pharmaceuticals Limited listed, and what industry does it belong to?
The company, Bafna Pharmaceuticals Limited, was listed in Feb 2020 and belongs to the Pharmaceuticals industry. Its NSE symbol is BAFNAPH.
What is the current shareholding pattern of the Bafna Pharmaceuticals Limited?
As of latest available update, promoters hold 88.74%, the public holds 11.26%, and Employee Trusts holds 0.00.
The Indian Community
Public Community
Settings
Discover the vibrant tapestry of 'The Indian Community' - a melting pot of diverse cultures, traditions, and values. Explore its rich heritage, festivals, and contributions, as this online hub celebrates the essence of India's people, connecting, inspiring, and fostering unity worldwide.
- Members
- 35
- Threads
- 180
